The sensitivity, specificity and accuracy for lymph node metastasis in predicting HIF-1 α-high PDACs and GLUT1-high PDACs were 52.9%, 72.5%, 62.7% and 51.0%, 70.6%, 60.8%, respectively; for incomplete enhancement, 66.7%, 68.6%, 67.6% and 64.7%, 66.7%, 65.7%, respectively; and for isoenhancement of PED, 37.3%, 82.4%, 59.8% and 39.2%, 84.3%, 61.8%, respectively. Here, SETD2 is linked to metastatic malignant neoplasm in the lymph nodes.